Skip to main content
. 2022 Nov 25;9(1):e001039. doi: 10.1136/bmjgast-2022-001039

Table 2.

Differences in the proportions of patients that reported positive outcomes to gut-directed hypnotherapy (GDH) by demographics and pretreatment preferences

Patient factors ≥ 30% improvement overall symptoms ≥ 30% improvement in abdominal pain Patient reported would not have had further benefit from face-to-face Would recommend remote GDH to friend/family member with similar symptoms
Gender distribution (females vs males) 22/36 (61%) vs 8/16 (50%), p=0.66 19/36 (53%) vs 5/16 (31%), p=0.26 20/36 (56%) vs 12/16 (75%), p=0.31 31/36 (86%) vs 16/16 (100%), p=0.15
Age group (>41 vs <41 years) 17/29 (59%) vs 13/23 (57%), p>0.99 12/29 (41%) vs 12/23 (52%), p=0.62 19/29 (66%) vs 13/23 (57%), p=0.71 27/29 (93%) vs 20/23 (87%) p=0.50
Preference for remote GDH at outset vs those that would have opted for face to face 15/27 (56%) vs 15/25 (60%), p=0.97 12/27 (44%) vs 12/25 (48%), p>0.99 21/27 (78%) vs 11/25 (44%), p=0.01* 26/27 (96%) vs 21/25 (84%), p=0.18
Distance from treatment centre >20 miles to residence vs those that live <20 miles away 11/19 (58%) vs 19/33 (58%), p=0.98 8/19 (42%) vs 16/33 (48%), p=0.66 10/19 (53%) vs 22/33 (67%), p=0.32 18/19 (95%) vs 29/33 (88%), p=0.64